Jonathan Goldin, MD, PhD
Specialty
Institutional Affiliation
Languages
Education
Fellowship
Internship
Degrees
Residency
Board Certification
Contact Information
Scientific Interests
Dr. Jonathan Goldin is involved in translational research in quantitative image analysis focusing on cardiothoracic applications.
Highlighted Publications
Brown MS, Lo P, Goldin JG, Barnoy E, Kim GH, McNitt-Gray MF, Aberle DR. Toward clinically usable CAD for lung cancer screening with computed tomography. Eur Radiol. 2014 Nov;24(11):2719-28. doi: 10.1007/s00330-014-3329-0. Epub 2014 Jul 24.
Lee RJ, Saylor PJ, Michaelson MD, Rothenberg SM, Smas ME, Miyamoto DT, Gurski CA, Xie W, Maheswaran S, Haber DA, Goldin JG, Smith MR. A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases. Clin Cancer Res. 2013 Jun 1;19(11):3088-94. doi: 10.1158/1078-0432.CCR-13-0319. Epub 2013 Apr 3.
Goldin JG. Computed tomography as a biomarker in clinical trials imaging. J Thorac Imaging. 2013 Sep;28(5):291-7. doi: 10.1097/RTI.0b013e3182a1d93d. Review.
Huo J, Okada K, van Rikxoort EM, Kim HJ, Alger JR, Pope WB, Goldin JG, Brown MS. Ensemble segmentation for GBM brain tumors on MR images using confidence-based averaging. Med Phys. 2013 Sep;40(9):093502. doi: 10.1118/1.4817475.
Brown MS, Chu GH, Kim HJ, Allen-Auerbach M, Poon C, Bridges J, Vidovic A, Ramakrishna B, Ho J, Morris MJ, Larson SM, Scher HI, Goldin JG. Computer-aided quantitative bone scan assessment of prostate cancer treatment response. Nucl Med Commun. 2012 Apr;33(4):384-94. doi: 10.1097/MNM.0b013e3283503ebf.